Infectious diseases trend monitorMonitor infectious disease trends driving IVD demandUnderstand local dynamics and how they impact infectious disease testing. Our comprehensive data and analysis on emerging and endemic infectious diseases from covid-19 to hepatitis helps your business strengthen its response to shifting disease trends and meet future demand for diagnostics and testing. Inquire
Each country report provides detailed information on trends in infectious diseases and the IVD market Epidemiological trends Policy trends and impact on infectious disease testing Testing landscape across patient journey in screening, diagnosis, treatment and management Reimbursement landscape Infectious disease test volumes by disease type and stage in patient journey Market size and 5-year CAGR forecast by technology (centralised, molecular, point-of-care and tissue diagnostics) for infectious diseases Competitive landscape with international v domestic market share, average selling price of top companies
Infectious diseases tracked include: Respiratory Tract Infections (RTIs) Influenza Covid-19 Other RTIs (RSV, adenovirus, bordetella) Virology Hepatitis (HBV, HCV) HPV HIV Sexually transmitted infections (STIs) Chlamydia (CT/NG) Other STIs Bacteriology Tuberculosis Hospital-acquired infections Vector-borne diseases Malaria Dengue
AustraliaMonitor the landscape as Australia’s government continues to invest in strengthening the country’s response to infectious diseases. Learn more
ChinaMonitor the landscape as China’s government is building up the country’s in vitro diagnostics testing capacity to strengthen the country’s response to infectious diseases. Learn more
JapanMonitor the landscape as Japan continues to focus on managing infectious diseases through prevention programmes, providing reimbursement for a comprehensive range of diagnostic tests. Learn more
KoreaMonitor the landscape as South Korea continues to invest in its laboratories to prepare for future public health crises and emerging infectious diseases. Learn more
IndiaMonitor the landscape as the Indian government increases its investment in surveillance and research to strengthen the country’s response to emerging infectious diseases. Learn more
IVD Size & Share PlusThe go-to source for tracking and understanding market size, share and trends in IVD. Granular break-out of data including more than 30 infectious diseases test segments and comprehensive coverage of international and domestic suppliers’ brand share across Asia, Europe, Latin America and the Middle East. Find out more
LabPRO PlusLab by lab profiles of centralised diagnostics (CEDx) labs, molecular diagnostics labs (MDx) and tissue diagnostics (TDx) labs across hospitals and commercial settings to help your business understand current infectious disease test, instrument and reagent usage of target customers. Find out more
Covid-19 Testing MonitorUnderstand and track global Covid-19 testing with the Covid-19 Testing Monitor – a go-to source for deep insights into the global testing ecosystem that helps the IVD industry and other organisations understand global covid test capacity. Track key developments and trends that impact the coronavirus testing market. Find out more